Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 203

1.

Initial Screening for Cervical Intraepithelial Neoplasia.

Vollmer RT.

Am J Clin Pathol. 2019 Jul 5;152(2):253. doi: 10.1093/ajcp/aqz058. No abstract available.

PMID:
31227830
2.

The Calculus of Serum PSA.

Vollmer RT.

Am J Clin Pathol. 2019 Aug 1;152(3):365-368. doi: 10.1093/ajcp/aqz042.

PMID:
31139828
3.

A review of the incidence of adenocarcinoma detected during surveillance for Barrett's esophagus.

Vollmer RT.

Hum Pathol. 2019 Feb;84:150-154. doi: 10.1016/j.humpath.2018.09.016. Epub 2018 Oct 5.

PMID:
30296519
4.

Serum Prostate-Specific Antigen (PSA) Concentration, PSA Mass, and Obesity: A Mathematical Analysis.

Vollmer RT.

Am J Clin Pathol. 2018 Feb 17;149(3):262-266. doi: 10.1093/ajcp/aqx157.

PMID:
29425257
5.

Defining Papillary Carcinoma of the Thyroid: A Short Review and Analysis.

Vollmer RT.

Am J Clin Pathol. 2017 Aug 1;148(2):100-107. doi: 10.1093/ajcp/aqx051.

PMID:
28898991
6.

Gleason Grading, Biochemical Failure, and Prostate Cancer-Specific Death.

Vollmer RT.

Am J Clin Pathol. 2017 Mar 1;147(3):273-277. doi: 10.1093/ajcp/aqw212.

PMID:
28395050
7.

A Review of Outcomes for Colorectal Adenomas.

Vollmer RT.

Am J Clin Pathol. 2016 Nov 1;146(5):567-571. doi: 10.1093/ajcp/aqw147.

PMID:
27677272
8.

A Review of Outcomes for Stage Ta Bladder Tumors.

Vollmer RT.

Am J Clin Pathol. 2016 Aug;146(2):215-20. doi: 10.1093/ajcp/aqw103. Review.

PMID:
27473739
9.

Detection of Occult Micrometastases in Patients With Clinical Stage I Non-Small-Cell Lung Cancer: A Prospective Analysis of Mature Results of CALGB 9761 (Alliance).

Martin LW, D'Cunha J, Wang X, Herzan D, Gu L, Abraham N, Demmy TL, Detterbeck FC, Groth SS, Harpole DH, Krasna MJ, Kernstine K, Kohman LJ, Patterson GA, Sugarbaker DJ, Vollmer RT, Maddaus MA, Kratzke RA.

J Clin Oncol. 2016 May 1;34(13):1484-91. doi: 10.1200/JCO.2015.63.4543. Epub 2016 Feb 29.

10.

Probabilistic issues with sentinel lymph nodes in malignant melanoma.

Vollmer RT.

Am J Clin Pathol. 2015 Sep;144(3):464-72. doi: 10.1309/AJCP50DKLTIUAZTE.

PMID:
26276777
11.

Disparate results between proliferation rates of surgically excised prostate tumors and an in vitro bioassay using sera from a positive randomized controlled trial.

Azrad M, Vollmer RT, Madden J, Polascik TJ, Snyder DC, Ruffin MT 4th, Moul JW, Brenner D, He X, Demark-Wahnefried W.

Biotech Histochem. 2015 Apr;90(3):184-9. doi: 10.3109/10520295.2014.976840. Epub 2014 Dec 1.

12.

A review of survival in mycosis fungoides.

Vollmer RT.

Am J Clin Pathol. 2014 May;141(5):706-11. doi: 10.1309/AJCPH2PHXFCX3BOX. Review.

PMID:
24713743
13.

A probabilistic analysis of mitotic counts in melanoma.

Vollmer RT.

Am J Clin Pathol. 2014 Feb;141(2):213-8. doi: 10.1309/AJCPFOV67CLZVPZZ.

PMID:
24436268
14.

Epidermal dynamics and patterns of intraepidermal melanoma.

Vollmer RT.

J Cutan Pathol. 2014 Mar;41(3):297-302. doi: 10.1111/cup.12280. Epub 2014 Jan 21.

PMID:
24354632
15.

Revisiting overdiagnosis and fatality in thyroid cancer.

Vollmer RT.

Am J Clin Pathol. 2014 Jan;141(1):128-32. doi: 10.1309/AJCP9TBSMWZVYPRR.

PMID:
24343746
16.

Flaxseed-derived enterolactone is inversely associated with tumor cell proliferation in men with localized prostate cancer.

Azrad M, Vollmer RT, Madden J, Dewhirst M, Polascik TJ, Snyder DC, Ruffin MT, Moul JW, Brenner DE, Demark-Wahnefried W.

J Med Food. 2013 Apr;16(4):357-60. doi: 10.1089/jmf.2012.0159.

17.

Intratumoral inflammation is associated with more aggressive prostate cancer.

Klink JC, Bañez LL, Gerber L, Lark A, Vollmer RT, Freedland SJ.

World J Urol. 2013 Dec;31(6):1497-503. doi: 10.1007/s00345-013-1065-8. Epub 2013 Apr 2.

PMID:
23546767
18.

Prostatic alpha-linolenic acid (ALA) is positively associated with aggressive prostate cancer: a relationship which may depend on genetic variation in ALA metabolism.

Azrad M, Zhang K, Vollmer RT, Madden J, Polascik TJ, Snyder DC, Ruffin MT, Moul JW, Brenner D, Hardy RW, Demark-Wahnefried W.

PLoS One. 2012;7(12):e53104. doi: 10.1371/journal.pone.0053104. Epub 2012 Dec 28.

19.

Dermatopathology of the foreskin: an institutional experience of over 400 cases.

West DS, Papalas JA, Selim MA, Vollmer RT.

J Cutan Pathol. 2013 Jan;40(1):11-8. doi: 10.1111/cup.12032. Epub 2012 Oct 25.

PMID:
23106553
20.

The dynamics of death in melanoma.

Vollmer RT.

J Cutan Pathol. 2012 Dec;39(12):1075-82. doi: 10.1111/cup.12031. Epub 2012 Oct 17.

PMID:
23072441
21.

The dynamics of death in prostate cancer.

Vollmer RT.

Am J Clin Pathol. 2012 Jun;137(6):957-62. doi: 10.1309/AJCPJK9V9LUMUETV.

PMID:
22586055
22.

Effect of low-fat diets on plasma levels of NF-κB-regulated inflammatory cytokines and angiogenic factors in men with prostate cancer.

Heymach JV, Shackleford TJ, Tran HT, Yoo SY, Do KA, Wergin M, Saintigny P, Vollmer RT, Polascik TJ, Snyder DC, Ruffin MT 4th, Yan S, Dewhirst M, Kunnumakkara AB, Aggarwal BB, Demark-Wahnefried W.

Cancer Prev Res (Phila). 2011 Oct;4(10):1590-8. doi: 10.1158/1940-6207.CAPR-10-0136. Epub 2011 Jul 15.

23.

Prostate biopsies from black men express higher levels of aggressive disease biomarkers than prostate biopsies from white men.

Kim HS, Moreira DM, Jayachandran J, Gerber L, Bañez LL, Vollmer RT, Lark AL, Donovan MJ, Powell D, Khan FM, Freedland SJ.

Prostate Cancer Prostatic Dis. 2011 Sep;14(3):262-5. doi: 10.1038/pcan.2011.18. Epub 2011 Apr 26.

PMID:
21519348
24.

Editorial comment.

Vollmer RT.

J Urol. 2011 Jan;185(1):125. doi: 10.1016/j.juro.2010.08.105. Epub 2010 Nov 12. No abstract available.

PMID:
21074213
25.

Osteosarcoma after radiotherapy for prostate cancer.

Papalas JA, Wylie JD, Vollmer RT.

Ann Diagn Pathol. 2011 Jun;15(3):194-7. doi: 10.1016/j.anndiagpath.2010.02.010. Epub 2010 May 6.

PMID:
20952292
26.

PTEN genomic deletion is an early event associated with ERG gene rearrangements in prostate cancer.

Bismar TA, Yoshimoto M, Vollmer RT, Duan Q, Firszt M, Corcos J, Squire JA.

BJU Int. 2011 Feb;107(3):477-85. doi: 10.1111/j.1464-410X.2010.09470.x.

27.

Prognostic significance of mucin and p53 expression in stage IB non-small cell lung cancer: a laboratory companion study to CALGB 9633.

Graziano SL, Gu L, Wang X, Tatum AH, Vollmer RT, Strauss GM, Kratzke R, Dudek AZ, Vokes EE, Green MR; Cancer and Leukemia Group B; North Central Cancer Treatment Group; Radiation Therapy Oncology Group.

J Thorac Oncol. 2010 Jun;5(6):810-7.

28.

Comparison of 2004 and 1973 World Health Organization grading systems and their relationship to pathologic staging for predicting long-term prognosis in patients with urothelial carcinoma.

Cao D, Vollmer RT, Luly J, Jain S, Roytman TM, Ferris CW, Hudson MA.

Urology. 2010 Sep;76(3):593-9. doi: 10.1016/j.urology.2010.01.032. Epub 2010 Apr 8.

PMID:
20381131
29.

Editorial comment.

Vollmer RT.

J Urol. 2010 May;183(5):1814; discussion 1815. doi: 10.1016/j.juro.2010.01.101. Epub 2010 Mar 29. No abstract available.

PMID:
20303117
30.

Association between statins and prostate tumor inflammatory infiltrate in men undergoing radical prostatectomy.

Bañez LL, Klink JC, Jayachandran J, Lark AL, Gerber L, Hamilton RJ, Masko EM, Vollmer RT, Freedland SJ.

Cancer Epidemiol Biomarkers Prev. 2010 Mar;19(3):722-8. doi: 10.1158/1055-9965.EPI-09-1074. Epub 2010 Feb 16.

31.

Dissecting the dynamics of serum prostate-specific antigen.

Vollmer RT.

Am J Clin Pathol. 2010 Feb;133(2):187-93. doi: 10.1309/AJCP3CJR3IDRCFEO.

PMID:
20093227
32.

Editorial comment.

Vollmer RT.

J Urol. 2010 Mar;183(3):1001-2. doi: 10.1016/j.juro.2009.11.122. Epub 2010 Jan 20. No abstract available.

PMID:
20089267
33.

Sarcomatoid mesothelioma: a clinical-pathologic correlation of 326 cases.

Klebe S, Brownlee NA, Mahar A, Burchette JL, Sporn TA, Vollmer RT, Roggli VL.

Mod Pathol. 2010 Mar;23(3):470-9. doi: 10.1038/modpathol.2009.180. Epub 2010 Jan 15.

34.

Syndecan-1 expression in prostate cancer and its value as biomarker for disease progression.

Brimo F, Vollmer RT, Friszt M, Corcos J, Bismar TA.

BJU Int. 2010 Aug;106(3):418-23. doi: 10.1111/j.1464-410X.2009.09099.x. Epub 2009 Dec 11.

35.

Paget disease of the vulva: a study of 56 cases.

Shaco-Levy R, Bean SM, Vollmer RT, Jewell E, Jones EL, Valdes CL, Bentley RC, Selim MA, Robboy SJ.

Eur J Obstet Gynecol Reprod Biol. 2010 Mar;149(1):86-91. doi: 10.1016/j.ejogrb.2009.11.003. Epub 2009 Dec 6.

PMID:
19969410
36.

Paget disease of the vulva: a histologic study of 56 cases correlating pathologic features and disease course.

Shaco-Levy R, Bean SM, Vollmer RT, Papalas JA, Bentley RC, Selim MA, Robboy SJ.

Int J Gynecol Pathol. 2010 Jan;29(1):69-78. doi: 10.1097/PGP.0b013e3181b1cc5e.

PMID:
19952933
37.

Accuracy of urine cytology and the significance of an atypical category.

Brimo F, Vollmer RT, Case B, Aprikian A, Kassouf W, Auger M.

Am J Clin Pathol. 2009 Nov;132(5):785-93. doi: 10.1309/AJCPPRZLG9KT9AXL.

PMID:
19846822
38.

Patterns of GRP78 and MTJ1 expression in primary cutaneous malignant melanoma.

Papalas JA, Vollmer RT, Gonzalez-Gronow M, Pizzo SV, Burchette J, Youens KE, Johnson KB, Selim MA.

Mod Pathol. 2010 Jan;23(1):134-43. doi: 10.1038/modpathol.2009.152. Epub 2009 Oct 16.

39.

Primary lung cancer vs metastatic breast cancer: a probabilistic approach.

Vollmer RT.

Am J Clin Pathol. 2009 Sep;132(3):391-5. doi: 10.1309/AJCPDIP12IUGVRQR.

PMID:
19687315
40.
41.

The significance of syndecan-1 expression in patients treated with radical prostatectomy. Commentary.

Brimo F, Vollmer RT, Bismar TA.

BJU Int. 2009 Jul;104(1):125. doi: 10.1111/j.1464-410X.2009.08722_3.x. No abstract available.

42.

p16 Improves interobserver agreement in diagnosis of anal intraepithelial neoplasia.

Bean SM, Meara RS, Vollmer RT, Conner MG, Crowe DR, Novak L, Eltoum IA, Robboy SJ, Chhieng DC.

J Low Genit Tract Dis. 2009 Jul;13(3):145-53. doi: 10.1097/LGT.0b013e3181934486.

PMID:
19550211
43.

Personalized prediction of tumor response and cancer progression on prostate needle biopsy.

Donovan MJ, Khan FM, Fernandez G, Mesa-Tejada R, Sapir M, Zubek VB, Powell D, Fogarasi S, Vengrenyuk Y, Teverovskiy M, Segal MR, Karnes RJ, Gaffey TA, Busch C, Haggman M, Hlavcak P, Freedland SJ, Vollmer RT, Albertsen P, Costa J, Cordon-Cardo C.

J Urol. 2009 Jul;182(1):125-32. doi: 10.1016/j.juro.2009.02.135. Epub 2009 May 17.

PMID:
19450827
44.

Differential diagnosis in immunohistochemistry with Bayes theorem.

Vollmer RT.

Am J Clin Pathol. 2009 May;131(5):723-30. doi: 10.1309/AJCPKF4L6UKBIYSP.

PMID:
19369634
45.

Fraction of positive cores in prostate needle biopsy is significantly predictive of pathological stage in radical prostatectomy.

Brimo F, Vollmer RT, Bismar TA.

Histopathology. 2009 Feb;54(3):374-5. doi: 10.1111/j.1365-2559.2009.03228.x. No abstract available.

PMID:
19236514
46.

Phosphorylated epidermal growth factor receptor and cyclooxygenase-2 expression in localized non-small cell lung cancer.

Kim SJ, Rabbani ZN, Dong F, Vollmer RT, Schreiber EG, Dewhirst MW, Vujaskovic Z, Kelley MJ.

Med Oncol. 2010 Mar;27(1):91-7. doi: 10.1007/s12032-009-9178-z. Epub 2009 Feb 24.

47.

Fascin regulates prostate cancer cell invasion and is associated with metastasis and biochemical failure in prostate cancer.

Darnel AD, Behmoaram E, Vollmer RT, Corcos J, Bijian K, Sircar K, Su J, Jiao J, Alaoui-Jamali MA, Bismar TA.

Clin Cancer Res. 2009 Feb 15;15(4):1376-83. doi: 10.1158/1078-0432.CCR-08-1789.

48.

Panel vs. single marker for discriminating desmoplastic trichoepithelioma from morpheaform/infiltrative basal cell carcinoma.

Vollmer RT.

J Cutan Pathol. 2009 Feb;36(2):283; author reply 284. doi: 10.1111/j.1600-0560.2008.01047.x. No abstract available.

PMID:
19208081
49.
50.

Percentage of tumor in prostatectomy specimens: a study of American Veterans.

Vollmer RT.

Am J Clin Pathol. 2009 Jan;131(1):86-91. doi: 10.1309/AJCPX5MAMNMFE6FQ.

PMID:
19095570

Supplemental Content

Loading ...
Support Center